The first case of coronavirus disease (COVID-19) in Finland was confirmed on 29 January 2020. No secondary cases were detected. We describe the clinical picture and laboratory findings 3–23 days since the first symptoms. The SARS-CoV-2/Finland/1/2020 virus strain was isolated, the genome showing a single nucleotide substitution to the reference strain from Wuhan. Neutralising antibody response appeared within 9 days along with specific IgM and IgG response, targeting particularly nucleocapsid and spike proteins.
All Keywords
【저자키워드】 COVID-19, whole-genome sequencing, antibodies, SARS-CoV-2, coronavirus, Humoral immunity, immunofluorescence assay, western blotting, microneutralisation test, 【초록키워드】 coronavirus disease, Genome, Laboratory, nucleocapsid, clinical picture, Wuhan, single nucleotide, Spike proteins, IgG response, neutralising antibody response, first symptoms, specific IgM, virus strain, secondary case, 【제목키워드】 molecular,
【저자키워드】 COVID-19, whole-genome sequencing, antibodies, SARS-CoV-2, coronavirus, Humoral immunity, immunofluorescence assay, western blotting, microneutralisation test, 【초록키워드】 coronavirus disease, Genome, Laboratory, nucleocapsid, clinical picture, Wuhan, single nucleotide, Spike proteins, IgG response, neutralising antibody response, first symptoms, specific IgM, virus strain, secondary case, 【제목키워드】 molecular,